

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of meiosis I (GO:0060631) | 8.98971985 |
| 2 | regulation of DNA methylation (GO:0044030) | 8.31311974 |
| 3 | regulation of female gonad development (GO:2000194) | 7.71041229 |
| 4 | piRNA metabolic process (GO:0034587) | 7.27987304 |
| 5 | regulation of translational termination (GO:0006449) | 6.56533591 |
| 6 | meiotic cell cycle (GO:0051321) | 6.38102612 |
| 7 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 6.35627102 |
| 8 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 6.35627102 |
| 9 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 6.35627102 |
| 10 | female gamete generation (GO:0007292) | 6.06345628 |
| 11 | DNA methylation involved in gamete generation (GO:0043046) | 5.87704015 |
| 12 | regulation of histone H3-K9 methylation (GO:0051570) | 5.56642142 |
| 13 | regulation of steroid hormone secretion (GO:2000831) | 5.49228337 |
| 14 | regulation of acrosome reaction (GO:0060046) | 5.14754309 |
| 15 | relaxation of smooth muscle (GO:0044557) | 4.99497765 |
| 16 | oocyte development (GO:0048599) | 4.81018079 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.71165875 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 4.71165875 |
| 19 | synapsis (GO:0007129) | 4.55129698 |
| 20 | oogenesis (GO:0048477) | 4.50025779 |
| 21 | regulation of cell maturation (GO:1903429) | 4.49443370 |
| 22 | gene silencing by RNA (GO:0031047) | 4.48372544 |
| 23 | positive regulation of chromosome segregation (GO:0051984) | 4.46138286 |
| 24 | centriole replication (GO:0007099) | 4.42264058 |
| 25 | primitive streak formation (GO:0090009) | 4.37702905 |
| 26 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.37650754 |
| 27 | NADH metabolic process (GO:0006734) | 4.33353917 |
| 28 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.31702646 |
| 29 | retinal cone cell development (GO:0046549) | 4.18636345 |
| 30 | multicellular organism reproduction (GO:0032504) | 4.16895065 |
| 31 | establishment of chromosome localization (GO:0051303) | 4.12295490 |
| 32 | negative regulation of reproductive process (GO:2000242) | 4.11672563 |
| 33 | synaptonemal complex assembly (GO:0007130) | 4.01772144 |
| 34 | regulation of meiosis (GO:0040020) | 3.99195705 |
| 35 | negative regulation of histone methylation (GO:0031061) | 3.91409325 |
| 36 | oxaloacetate metabolic process (GO:0006107) | 3.90815458 |
| 37 | chromosome organization involved in meiosis (GO:0070192) | 3.86360480 |
| 38 | mitotic metaphase plate congression (GO:0007080) | 3.85465196 |
| 39 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.84849617 |
| 40 | positive regulation of gastrulation (GO:2000543) | 3.84150679 |
| 41 | activation of protein kinase A activity (GO:0034199) | 3.76100201 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 3.73009888 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72859244 |
| 44 | protein localization to kinetochore (GO:0034501) | 3.67947885 |
| 45 | male meiosis (GO:0007140) | 3.64473636 |
| 46 | proline transport (GO:0015824) | 3.63374143 |
| 47 | synaptic vesicle maturation (GO:0016188) | 3.62080060 |
| 48 | genitalia morphogenesis (GO:0035112) | 3.61248311 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60589233 |
| 50 | vesicle transport along microtubule (GO:0047496) | 3.59569424 |
| 51 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.59320336 |
| 52 | synaptonemal complex organization (GO:0070193) | 3.57816875 |
| 53 | male meiosis I (GO:0007141) | 3.50553259 |
| 54 | cellular response to ethanol (GO:0071361) | 3.49218426 |
| 55 | mitotic chromosome condensation (GO:0007076) | 3.47353464 |
| 56 | microtubule severing (GO:0051013) | 3.47188033 |
| 57 | establishment of protein localization to Golgi (GO:0072600) | 3.46347526 |
| 58 | endoderm development (GO:0007492) | 3.45065893 |
| 59 | interkinetic nuclear migration (GO:0022027) | 3.44968897 |
| 60 | succinate metabolic process (GO:0006105) | 3.43752258 |
| 61 | regulation of meiotic cell cycle (GO:0051445) | 3.40931500 |
| 62 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.40119869 |
| 63 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.37351176 |
| 64 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.33631562 |
| 65 | tricarboxylic acid cycle (GO:0006099) | 3.32939561 |
| 66 | positive regulation of steroid hormone secretion (GO:2000833) | 3.29833651 |
| 67 | neurotransmitter secretion (GO:0007269) | 3.29098510 |
| 68 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.28085284 |
| 69 | centrosome duplication (GO:0051298) | 3.27556923 |
| 70 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.26713689 |
| 71 | regulation of early endosome to late endosome transport (GO:2000641) | 3.26038294 |
| 72 | N-terminal protein amino acid acetylation (GO:0006474) | 3.25209444 |
| 73 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.24623500 |
| 74 | paraxial mesoderm development (GO:0048339) | 3.22818112 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 3.14625589 |
| 76 | glutamate secretion (GO:0014047) | 3.13118404 |
| 77 | positive regulation of nuclease activity (GO:0032075) | 3.11678855 |
| 78 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.11408717 |
| 79 | metaphase plate congression (GO:0051310) | 3.11293149 |
| 80 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.09305344 |
| 81 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.08832931 |
| 82 | definitive hemopoiesis (GO:0060216) | 3.08107284 |
| 83 | nucleus organization (GO:0006997) | 3.07465655 |
| 84 | protein maturation by protein folding (GO:0022417) | 3.07323735 |
| 85 | synaptic vesicle exocytosis (GO:0016079) | 3.03972508 |
| 86 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.02609599 |
| 87 | meiotic cell cycle process (GO:1903046) | 3.02536240 |
| 88 | labyrinthine layer development (GO:0060711) | 3.01377813 |
| 89 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.00998492 |
| 90 | protein localization to chromosome (GO:0034502) | 3.00609378 |
| 91 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.00495112 |
| 92 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.00257792 |
| 93 | somite rostral/caudal axis specification (GO:0032525) | 2.98652747 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96553633 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.96553633 |
| 96 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96130005 |
| 97 | meiotic nuclear division (GO:0007126) | 2.94173853 |
| 98 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.94061169 |
| 99 | cellular potassium ion homeostasis (GO:0030007) | 2.93972710 |
| 100 | peptidyl-lysine dimethylation (GO:0018027) | 2.92696221 |
| 101 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.92242469 |
| 102 | NLS-bearing protein import into nucleus (GO:0006607) | 2.90689608 |
| 103 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.90243500 |
| 104 | negative regulation of meiosis (GO:0045835) | 2.90179847 |
| 105 | negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736) | 2.90150960 |
| 106 | centriole assembly (GO:0098534) | 2.89915974 |
| 107 | negative regulation of muscle hypertrophy (GO:0014741) | 2.89865101 |
| 108 | hypotonic response (GO:0006971) | 2.88280271 |
| 109 | locomotory exploration behavior (GO:0035641) | 2.88213586 |
| 110 | positive regulation of histone methylation (GO:0031062) | 2.86750172 |
| 111 | positive regulation of humoral immune response (GO:0002922) | 2.86245524 |
| 112 | regulation of nuclease activity (GO:0032069) | 2.85330005 |
| 113 | nuclear pore organization (GO:0006999) | 2.83707886 |
| 114 | glycine transport (GO:0015816) | 2.82774751 |
| 115 | intestinal epithelial cell development (GO:0060576) | 2.81680680 |
| 116 | regulation of chromatin silencing (GO:0031935) | 2.80119183 |
| 117 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.79946002 |
| 118 | regulation of cofactor metabolic process (GO:0051193) | 2.79940461 |
| 119 | regulation of coenzyme metabolic process (GO:0051196) | 2.79940461 |
| 120 | fertilization (GO:0009566) | 2.79671655 |
| 121 | oocyte maturation (GO:0001556) | 2.78958362 |
| 122 | regulation of sequestering of triglyceride (GO:0010889) | 2.78954379 |
| 123 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.76697111 |
| 124 | neuromuscular process controlling posture (GO:0050884) | 2.76496090 |
| 125 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.76132187 |
| 126 | sodium ion export (GO:0071436) | 2.74024527 |
| 127 | neuronal action potential propagation (GO:0019227) | 2.73733461 |
| 128 | positive regulation of meiosis (GO:0045836) | 2.73651723 |
| 129 | meiosis I (GO:0007127) | 2.73136498 |
| 130 | protein targeting to Golgi (GO:0000042) | 2.72129354 |
| 131 | organelle transport along microtubule (GO:0072384) | 2.71947013 |
| 132 | dopamine biosynthetic process (GO:0042416) | 2.71646189 |
| 133 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.70306706 |
| 134 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.70236808 |
| 135 | regulation of endocrine process (GO:0044060) | 2.68517031 |
| 136 | histone H3-K9 demethylation (GO:0033169) | 2.66388484 |
| 137 | insulin secretion (GO:0030073) | 2.66372749 |
| 138 | negative regulation of hormone metabolic process (GO:0032351) | 2.64808345 |
| 139 | positive regulation of reproductive process (GO:2000243) | 2.64617693 |
| 140 | cellular response to unfolded protein (GO:0034620) | 2.64216533 |
| 141 | tricarboxylic acid metabolic process (GO:0072350) | 2.63815286 |
| 142 | positive regulation of meiotic cell cycle (GO:0051446) | 2.63548752 |
| 143 | response to xenobiotic stimulus (GO:0009410) | 2.63474650 |
| 144 | ER-nucleus signaling pathway (GO:0006984) | 2.63322075 |
| 145 | response to manganese ion (GO:0010042) | 2.63111242 |
| 146 | endoplasmic reticulum organization (GO:0007029) | 2.61364038 |
| 147 | reproduction (GO:0000003) | 2.59464775 |
| 148 | fatty acid homeostasis (GO:0055089) | 2.57432308 |
| 149 | spermatid nucleus differentiation (GO:0007289) | 2.56505064 |
| 150 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.55870658 |
| 151 | cellular response to arsenic-containing substance (GO:0071243) | 2.55281874 |
| 152 | valine metabolic process (GO:0006573) | 2.54320925 |
| 153 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.53922969 |
| 154 | vesicle coating (GO:0006901) | 2.53864530 |
| 155 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.53703987 |
| 156 | regulation of cholesterol storage (GO:0010885) | 2.53697358 |
| 157 | alanine transport (GO:0032328) | 2.53014014 |
| 158 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.52962962 |
| 159 | gene silencing (GO:0016458) | 2.51011982 |
| 160 | regulation of hormone biosynthetic process (GO:0046885) | 2.50891675 |
| 161 | DNA damage induced protein phosphorylation (GO:0006975) | 2.50481130 |
| 162 | regulation of ARF protein signal transduction (GO:0032012) | 2.50188581 |
| 163 | negative regulation of smooth muscle contraction (GO:0045986) | 2.50157901 |
| 164 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49196036 |
| 165 | positive regulation of vesicle fusion (GO:0031340) | 2.48156163 |
| 166 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.47628906 |
| 167 | pantothenate metabolic process (GO:0015939) | 2.47521535 |
| 168 | Golgi organization (GO:0007030) | 2.45416102 |
| 169 | protein retention in ER lumen (GO:0006621) | 2.43982296 |
| 170 | signal release (GO:0023061) | 2.42240633 |
| 171 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.41163623 |
| 172 | regulation of sulfur metabolic process (GO:0042762) | 2.40433883 |
| 173 | 2-oxoglutarate metabolic process (GO:0006103) | 2.38584405 |
| 174 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.37673394 |
| 175 | plasma membrane repair (GO:0001778) | 2.37259084 |
| 176 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.36551131 |
| 177 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.36428463 |
| 178 | growth hormone secretion (GO:0030252) | 2.35714138 |
| 179 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.35515727 |
| 180 | acylglycerol catabolic process (GO:0046464) | 2.35443220 |
| 181 | neutral lipid catabolic process (GO:0046461) | 2.35443220 |
| 182 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.35014656 |
| 183 | cellular response to topologically incorrect protein (GO:0035967) | 2.33406898 |
| 184 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.33389917 |
| 185 | triglyceride catabolic process (GO:0019433) | 2.33371923 |
| 186 | positive regulation of macroautophagy (GO:0016239) | 2.31990106 |
| 187 | low-density lipoprotein particle clearance (GO:0034383) | 2.31773984 |
| 188 | protein targeting to vacuole (GO:0006623) | 2.29826205 |
| 189 | protein targeting to lysosome (GO:0006622) | 2.29826205 |
| 190 | establishment of protein localization to vacuole (GO:0072666) | 2.29826205 |
| 191 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.29288616 |
| 192 | intracellular lipid transport (GO:0032365) | 2.28132298 |
| 193 | phospholipid dephosphorylation (GO:0046839) | 2.27049451 |
| 194 | lysine catabolic process (GO:0006554) | 2.26592558 |
| 195 | lysine metabolic process (GO:0006553) | 2.26592558 |
| 196 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.26065269 |
| 197 | suckling behavior (GO:0001967) | 2.25444364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.43869172 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.42121439 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.40378597 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.82654956 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.78131461 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.24661552 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.20642181 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.19392191 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.05264997 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.77807699 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69843826 |
| 12 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.66752385 |
| 13 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.61234412 |
| 14 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.61234412 |
| 15 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.61234412 |
| 16 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.61191782 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.33057925 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32154687 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.29268422 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.29073757 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21853339 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20995884 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.14592488 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.11647747 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10630697 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.10360491 |
| 27 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 2.00577439 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99870771 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97515405 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90135255 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.87650624 |
| 32 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.83280849 |
| 33 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.82485940 |
| 34 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82271587 |
| 35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.81747758 |
| 36 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.80971938 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80402963 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.78028052 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75175462 |
| 40 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.72572955 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68437244 |
| 42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68225835 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67475323 |
| 44 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.65994564 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.65758421 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62148452 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61285223 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.60369706 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59081462 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58997774 |
| 51 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.58583189 |
| 52 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58232863 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56717863 |
| 54 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.56501630 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55829800 |
| 56 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.55088165 |
| 57 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.54691027 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54355582 |
| 59 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.52208497 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.51704053 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51610489 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48464271 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48167611 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.47828867 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.45690297 |
| 66 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44392520 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.43018978 |
| 68 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.42235980 |
| 69 | RXR_22108803_ChIP-Seq_LS180_Human | 1.41897563 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41425278 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40884666 |
| 72 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.40017821 |
| 73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39826053 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39434514 |
| 75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39106428 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39071846 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38103441 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37259080 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34749699 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32979405 |
| 81 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32545805 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32533842 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31590377 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31570384 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31333427 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31161178 |
| 87 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29783732 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29453134 |
| 89 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29029270 |
| 90 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28998713 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28298966 |
| 92 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27953189 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.27877697 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25409898 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25304308 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23878466 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23696034 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23502181 |
| 99 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.22273040 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22272692 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22227731 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21080941 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20967871 |
| 104 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.20860506 |
| 105 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20860506 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20086224 |
| 107 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19394298 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19266635 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19266635 |
| 110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18954940 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17854974 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17387730 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17200564 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16071366 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15717780 |
| 116 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15535717 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.14882331 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13689543 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12957172 |
| 120 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.12879113 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11759416 |
| 122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10593457 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10294439 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09696224 |
| 125 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09472878 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09216374 |
| 127 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09145056 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09031818 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08718007 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08530079 |
| 131 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08308084 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07413439 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07021589 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06494255 |
| 135 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05739891 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05348876 |
| 137 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04888791 |
| 138 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04427522 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04090251 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03810553 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02716971 |
| 142 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.02220888 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02061943 |
| 144 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00340209 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00059281 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99938940 |
| 147 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99870663 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99722378 |
| 149 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99625680 |
| 150 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99553609 |
| 151 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.99154363 |
| 152 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99147956 |
| 153 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98523831 |
| 154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97514007 |
| 155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97488959 |
| 156 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97046609 |
| 157 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96923833 |
| 158 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96875087 |
| 159 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.96831562 |
| 160 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96721432 |
| 161 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96475123 |
| 162 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95975844 |
| 163 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95841839 |
| 164 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95765655 |
| 165 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95725398 |
| 166 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95580614 |
| 167 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.95213864 |
| 168 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95180027 |
| 169 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94952481 |
| 170 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94942807 |
| 171 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94456009 |
| 172 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94036782 |
| 173 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92970666 |
| 174 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92913449 |
| 175 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.92670387 |
| 176 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92644981 |
| 177 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92319708 |
| 178 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92033287 |
| 179 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91730515 |
| 180 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89969855 |
| 181 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89878675 |
| 182 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89847348 |
| 183 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89146523 |
| 184 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88812496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003718_maternal_effect | 6.63209801 |
| 2 | MP0003890_abnormal_embryonic-extraembry | 4.14142546 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.64817811 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.38113882 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.34615845 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.29965790 |
| 7 | MP0008789_abnormal_olfactory_epithelium | 3.03763157 |
| 8 | MP0004130_abnormal_muscle_cell | 2.99466314 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.79587355 |
| 10 | MP0003646_muscle_fatigue | 2.74881671 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.74025437 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.68846443 |
| 13 | MP0004270_analgesia | 2.58697757 |
| 14 | MP0005395_other_phenotype | 2.55897093 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.46958126 |
| 16 | MP0008057_abnormal_DNA_replication | 2.42812918 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.35987955 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.32843268 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.30267001 |
| 20 | MP0005499_abnormal_olfactory_system | 2.24482647 |
| 21 | MP0005394_taste/olfaction_phenotype | 2.24482647 |
| 22 | MP0000762_abnormal_tongue_morphology | 2.16717894 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.16569714 |
| 24 | MP0002234_abnormal_pharynx_morphology | 2.08189532 |
| 25 | MP0003123_paternal_imprinting | 2.06855406 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 2.00259266 |
| 27 | MP0008004_abnormal_stomach_pH | 1.96438137 |
| 28 | MP0002822_catalepsy | 1.94829413 |
| 29 | MP0004858_abnormal_nervous_system | 1.94732007 |
| 30 | MP0003699_abnormal_female_reproductive | 1.91962908 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.88284148 |
| 32 | MP0003195_calcinosis | 1.87806554 |
| 33 | MP0005535_abnormal_body_temperature | 1.87538967 |
| 34 | MP0004043_abnormal_pH_regulation | 1.86704954 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.85386862 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.82493112 |
| 37 | MP0004264_abnormal_extraembryonic_tissu | 1.77918691 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.77199096 |
| 39 | MP0009046_muscle_twitch | 1.74974579 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.74062509 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.71692657 |
| 42 | MP0002160_abnormal_reproductive_system | 1.71215339 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.68136348 |
| 44 | MP0002210_abnormal_sex_determination | 1.67387770 |
| 45 | MP0005275_abnormal_skin_tensile | 1.67350148 |
| 46 | MP0005410_abnormal_fertilization | 1.64128201 |
| 47 | MP0002796_impaired_skin_barrier | 1.59840630 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.58609022 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.58439019 |
| 50 | MP0003941_abnormal_skin_development | 1.57552770 |
| 51 | MP0003091_abnormal_cell_migration | 1.56907931 |
| 52 | MP0005647_abnormal_sex_gland | 1.54741011 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.54604256 |
| 54 | MP0005409_darkened_coat_color | 1.50827928 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.49308597 |
| 56 | MP0001929_abnormal_gametogenesis | 1.49238838 |
| 57 | MP0003303_peritoneal_inflammation | 1.49044504 |
| 58 | MP0000427_abnormal_hair_cycle | 1.45636712 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.40998294 |
| 60 | MP0009250_abnormal_appendicular_skeleto | 1.38363460 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.37934285 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.37885808 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.37597387 |
| 64 | MP0004134_abnormal_chest_morphology | 1.35959262 |
| 65 | MP0003075_altered_response_to | 1.35415921 |
| 66 | MP0005083_abnormal_biliary_tract | 1.34660038 |
| 67 | MP0005670_abnormal_white_adipose | 1.34383279 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.32979940 |
| 69 | MP0004233_abnormal_muscle_weight | 1.32478454 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.32267510 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.31545921 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30623400 |
| 73 | MP0002971_abnormal_brown_adipose | 1.30197828 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 1.29396743 |
| 75 | MP0009384_cardiac_valve_regurgitation | 1.29231494 |
| 76 | MP0000653_abnormal_sex_gland | 1.28625764 |
| 77 | MP0000604_amyloidosis | 1.27778133 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.26878934 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.26278824 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.25947540 |
| 81 | MP0003077_abnormal_cell_cycle | 1.25677599 |
| 82 | MP0002064_seizures | 1.25313612 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 1.24043194 |
| 84 | MP0002693_abnormal_pancreas_physiology | 1.22567643 |
| 85 | MP0001730_embryonic_growth_arrest | 1.22130189 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 1.21888854 |
| 87 | MP0003787_abnormal_imprinting | 1.21498598 |
| 88 | MP0005023_abnormal_wound_healing | 1.18704340 |
| 89 | MP0005623_abnormal_meninges_morphology | 1.18318621 |
| 90 | MP0003566_abnormal_cell_adhesion | 1.16604304 |
| 91 | MP0005501_abnormal_skin_physiology | 1.16055607 |
| 92 | MP0001968_abnormal_touch/_nociception | 1.15323671 |
| 93 | MP0005310_abnormal_salivary_gland | 1.14073598 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 1.13039185 |
| 95 | MP0002161_abnormal_fertility/fecundity | 1.11949495 |
| 96 | MP0009745_abnormal_behavioral_response | 1.11679552 |
| 97 | MP0005166_decreased_susceptibility_to | 1.11295003 |
| 98 | MP0002006_tumorigenesis | 1.09736718 |
| 99 | MP0003172_abnormal_lysosome_physiology | 1.09350733 |
| 100 | MP0010307_abnormal_tumor_latency | 1.08563193 |
| 101 | MP0002166_altered_tumor_susceptibility | 1.08145266 |
| 102 | MP0001145_abnormal_male_reproductive | 1.06934284 |
| 103 | MP0005503_abnormal_tendon_morphology | 1.05524593 |
| 104 | MP0002733_abnormal_thermal_nociception | 1.05522776 |
| 105 | MP0004510_myositis | 1.05331318 |
| 106 | MP0002332_abnormal_exercise_endurance | 1.04822673 |
| 107 | MP0003252_abnormal_bile_duct | 1.03646897 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 1.03222253 |
| 109 | MP0003279_aneurysm | 1.02814931 |
| 110 | MP0005360_urolithiasis | 1.02720672 |
| 111 | MP0004811_abnormal_neuron_physiology | 1.02641757 |
| 112 | MP0008877_abnormal_DNA_methylation | 1.02500082 |
| 113 | MP0002735_abnormal_chemical_nociception | 1.00827833 |
| 114 | MP0002233_abnormal_nose_morphology | 1.00339074 |
| 115 | MP0002009_preneoplasia | 1.00252664 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.98698302 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.98251336 |
| 118 | MP0003868_abnormal_feces_composition | 0.97517864 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.97375614 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 0.97060729 |
| 121 | MP0008058_abnormal_DNA_repair | 0.96600267 |
| 122 | MP0005389_reproductive_system_phenotype | 0.96318866 |
| 123 | MP0000383_abnormal_hair_follicle | 0.94828111 |
| 124 | MP0005621_abnormal_cell_physiology | 0.94499566 |
| 125 | MP0003329_amyloid_beta_deposits | 0.93719444 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.92927420 |
| 127 | MP0004924_abnormal_behavior | 0.92927420 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.92861387 |
| 129 | MP0001881_abnormal_mammary_gland | 0.92854408 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.92849565 |
| 131 | MP0006138_congestive_heart_failure | 0.92054516 |
| 132 | MP0002060_abnormal_skin_morphology | 0.91763308 |
| 133 | MP0000358_abnormal_cell_content/ | 0.91247224 |
| 134 | MP0003633_abnormal_nervous_system | 0.89550674 |
| 135 | MP0000733_abnormal_muscle_development | 0.89337900 |
| 136 | MP0003879_abnormal_hair_cell | 0.87063763 |
| 137 | MP0005334_abnormal_fat_pad | 0.83353718 |
| 138 | MP0008569_lethality_at_weaning | 0.83207785 |
| 139 | MP0009840_abnormal_foam_cell | 0.83205224 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.82073649 |
| 141 | MP0006054_spinal_hemorrhage | 0.82066408 |
| 142 | MP0004272_abnormal_basement_membrane | 0.81510497 |
| 143 | MP0000516_abnormal_urinary_system | 0.80583048 |
| 144 | MP0005367_renal/urinary_system_phenotyp | 0.80583048 |
| 145 | MP0005508_abnormal_skeleton_morphology | 0.80021692 |
| 146 | MP0003453_abnormal_keratinocyte_physiol | 0.79424060 |
| 147 | MP0001970_abnormal_pain_threshold | 0.79302056 |
| 148 | MP0003935_abnormal_craniofacial_develop | 0.77789344 |
| 149 | MP0001119_abnormal_female_reproductive | 0.76844223 |
| 150 | MP0005332_abnormal_amino_acid | 0.76620643 |
| 151 | MP0002086_abnormal_extraembryonic_tissu | 0.75958346 |
| 152 | MP0002118_abnormal_lipid_homeostasis | 0.75782167 |
| 153 | MP0002269_muscular_atrophy | 0.74857627 |
| 154 | MP0002896_abnormal_bone_mineralization | 0.74677404 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.74305226 |
| 156 | MP0010329_abnormal_lipoprotein_level | 0.74077166 |
| 157 | MP0000350_abnormal_cell_proliferation | 0.73933394 |
| 158 | MP0002067_abnormal_sensory_capabilities | 0.73862981 |
| 159 | MP0001672_abnormal_embryogenesis/_devel | 0.73742681 |
| 160 | MP0005380_embryogenesis_phenotype | 0.73742681 |
| 161 | MP0002127_abnormal_cardiovascular_syste | 0.73669431 |
| 162 | MP0005319_abnormal_enzyme/_coenzyme | 0.72969514 |
| 163 | MP0002572_abnormal_emotion/affect_behav | 0.72158679 |
| 164 | MP0005187_abnormal_penis_morphology | 0.71972544 |
| 165 | MP0004087_abnormal_muscle_fiber | 0.71746409 |
| 166 | MP0004036_abnormal_muscle_relaxation | 0.71654557 |
| 167 | MP0005248_abnormal_Harderian_gland | 0.71393726 |
| 168 | MP0004947_skin_inflammation | 0.71217615 |
| 169 | MP0009379_abnormal_foot_pigmentation | 0.71038934 |
| 170 | MP0003698_abnormal_male_reproductive | 0.70402273 |
| 171 | MP0000609_abnormal_liver_physiology | 0.69670916 |
| 172 | MP0001756_abnormal_urination | 0.69613222 |
| 173 | MP0003953_abnormal_hormone_level | 0.68434687 |
| 174 | MP0004808_abnormal_hematopoietic_stem | 0.64540916 |
| 175 | MP0005384_cellular_phenotype | 0.64312505 |
| 176 | MP0003755_abnormal_palate_morphology | 0.61416323 |
| 177 | MP0002128_abnormal_blood_circulation | 0.60689644 |
| 178 | MP0000759_abnormal_skeletal_muscle | 0.59150882 |
| 179 | MP0005164_abnormal_response_to | 0.58855727 |
| 180 | MP0000377_abnormal_hair_follicle | 0.58817040 |
| 181 | MP0002998_abnormal_bone_remodeling | 0.58690053 |
| 182 | MP0003448_altered_tumor_morphology | 0.58654417 |
| 183 | MP0008932_abnormal_embryonic_tissue | 0.58552246 |
| 184 | MP0005197_abnormal_uvea_morphology | 0.58239109 |
| 185 | MP0001915_intracranial_hemorrhage | 0.58129672 |
| 186 | MP0002084_abnormal_developmental_patter | 0.55081743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Supernumerary spleens (HP:0009799) | 6.27516192 |
| 2 | Facial hemangioma (HP:0000329) | 5.13162579 |
| 3 | Osteomalacia (HP:0002749) | 4.21506934 |
| 4 | Abdominal situs inversus (HP:0003363) | 4.00196644 |
| 5 | Abnormality of abdominal situs (HP:0011620) | 4.00196644 |
| 6 | Metaphyseal dysplasia (HP:0100255) | 3.89794477 |
| 7 | Hypophosphatemic rickets (HP:0004912) | 3.76516826 |
| 8 | Ankle contracture (HP:0006466) | 3.75732064 |
| 9 | Fair hair (HP:0002286) | 3.71160326 |
| 10 | Capillary hemangiomas (HP:0005306) | 3.62676107 |
| 11 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.61831792 |
| 12 | Conjunctival telangiectasia (HP:0000524) | 3.59855358 |
| 13 | Anterior segment dysgenesis (HP:0007700) | 3.52835291 |
| 14 | Wrist flexion contracture (HP:0001239) | 3.49863450 |
| 15 | Global brain atrophy (HP:0002283) | 3.48743378 |
| 16 | Lip pit (HP:0100267) | 3.43511730 |
| 17 | Gonadotropin excess (HP:0000837) | 3.36815172 |
| 18 | Azoospermia (HP:0000027) | 3.28495240 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.26882386 |
| 20 | Visual hallucinations (HP:0002367) | 3.23297133 |
| 21 | Malnutrition (HP:0004395) | 3.13929484 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.13725778 |
| 23 | Median cleft lip (HP:0000161) | 3.07020094 |
| 24 | Oligodactyly (hands) (HP:0001180) | 2.95295456 |
| 25 | Hypoglycemic coma (HP:0001325) | 2.91362880 |
| 26 | Progressive inability to walk (HP:0002505) | 2.91107588 |
| 27 | Hip contracture (HP:0003273) | 2.88061129 |
| 28 | Facial diplegia (HP:0001349) | 2.87040746 |
| 29 | Abnormal pancreas size (HP:0012094) | 2.86904155 |
| 30 | Dysmetric saccades (HP:0000641) | 2.82500719 |
| 31 | Cone-rod dystrophy (HP:0000548) | 2.79246935 |
| 32 | Short tibia (HP:0005736) | 2.77060723 |
| 33 | Stillbirth (HP:0003826) | 2.76970283 |
| 34 | Lower limb asymmetry (HP:0100559) | 2.76195993 |
| 35 | Annular pancreas (HP:0001734) | 2.75649009 |
| 36 | Resting tremor (HP:0002322) | 2.73140808 |
| 37 | Knee flexion contracture (HP:0006380) | 2.72351119 |
| 38 | Bundle branch block (HP:0011710) | 2.67600730 |
| 39 | Hypoplasia of the fovea (HP:0007750) | 2.67558538 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.67558538 |
| 41 | Metaphyseal irregularity (HP:0003025) | 2.66112956 |
| 42 | Disinhibition (HP:0000734) | 2.64712350 |
| 43 | Generalized hypopigmentation of hair (HP:0011358) | 2.61938395 |
| 44 | Aortic aneurysm (HP:0004942) | 2.59721202 |
| 45 | Abnormal spermatogenesis (HP:0008669) | 2.56820724 |
| 46 | Failure to thrive in infancy (HP:0001531) | 2.55084570 |
| 47 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.52694608 |
| 48 | Oligomenorrhea (HP:0000876) | 2.50189813 |
| 49 | Infertility (HP:0000789) | 2.50158213 |
| 50 | Male infertility (HP:0003251) | 2.50088546 |
| 51 | Shallow orbits (HP:0000586) | 2.48723831 |
| 52 | Spinal cord compression (HP:0002176) | 2.47632159 |
| 53 | Tetraplegia (HP:0002445) | 2.47121123 |
| 54 | Focal motor seizures (HP:0011153) | 2.45380552 |
| 55 | Inappropriate behavior (HP:0000719) | 2.45250357 |
| 56 | Hyperglycemia (HP:0003074) | 2.43862292 |
| 57 | Cystic hygroma (HP:0000476) | 2.41098713 |
| 58 | Anhidrosis (HP:0000970) | 2.39845338 |
| 59 | Myokymia (HP:0002411) | 2.39102226 |
| 60 | Cranial hyperostosis (HP:0004437) | 2.37846339 |
| 61 | Upper motor neuron abnormality (HP:0002127) | 2.37353882 |
| 62 | Hand muscle atrophy (HP:0009130) | 2.37101342 |
| 63 | Striae distensae (HP:0001065) | 2.36804416 |
| 64 | Action tremor (HP:0002345) | 2.36721686 |
| 65 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.36307350 |
| 66 | Absent septum pellucidum (HP:0001331) | 2.35374950 |
| 67 | Absence seizures (HP:0002121) | 2.35024805 |
| 68 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.34662304 |
| 69 | Diminished motivation (HP:0000745) | 2.30758675 |
| 70 | Generalized tonic-clonic seizures (HP:0002069) | 2.29674731 |
| 71 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29615097 |
| 72 | Abnormal auditory evoked potentials (HP:0006958) | 2.28739362 |
| 73 | Atonic seizures (HP:0010819) | 2.26587367 |
| 74 | Papilledema (HP:0001085) | 2.26584972 |
| 75 | Enlarged penis (HP:0000040) | 2.25642619 |
| 76 | Truncal obesity (HP:0001956) | 2.24050016 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.23621128 |
| 78 | Abnormality of the fovea (HP:0000493) | 2.22736267 |
| 79 | Impaired social interactions (HP:0000735) | 2.22698815 |
| 80 | Abnormal social behavior (HP:0012433) | 2.22698815 |
| 81 | Apathy (HP:0000741) | 2.22184190 |
| 82 | Abnormality of the anterior chamber (HP:0000593) | 2.21447977 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.20485885 |
| 84 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.20235610 |
| 85 | Complete atrioventricular canal defect (HP:0001674) | 2.19825532 |
| 86 | Impaired pain sensation (HP:0007328) | 2.19741420 |
| 87 | Abnormality of pain sensation (HP:0010832) | 2.19741420 |
| 88 | Muscle stiffness (HP:0003552) | 2.18918472 |
| 89 | Abnormality of the septum pellucidum (HP:0007375) | 2.17386124 |
| 90 | Gout (HP:0001997) | 2.17164816 |
| 91 | Retinal atrophy (HP:0001105) | 2.15703290 |
| 92 | Termporal pattern (HP:0011008) | 2.15018820 |
| 93 | Insidious onset (HP:0003587) | 2.15018820 |
| 94 | Lower limb hyperreflexia (HP:0002395) | 2.13740204 |
| 95 | Postural instability (HP:0002172) | 2.12960665 |
| 96 | Abnormality of the labia minora (HP:0012880) | 2.12187807 |
| 97 | Urinary urgency (HP:0000012) | 2.11436420 |
| 98 | Hematochezia (HP:0002573) | 2.08941101 |
| 99 | Shoulder girdle muscle weakness (HP:0003547) | 2.08925527 |
| 100 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08710011 |
| 101 | Febrile seizures (HP:0002373) | 2.08540340 |
| 102 | Acute myeloid leukemia (HP:0004808) | 2.07478364 |
| 103 | Hydroureter (HP:0000072) | 2.07236640 |
| 104 | Ketoacidosis (HP:0001993) | 2.06155401 |
| 105 | Hypokinesia (HP:0002375) | 2.06049995 |
| 106 | Buphthalmos (HP:0000557) | 2.04636605 |
| 107 | Mutism (HP:0002300) | 2.04386752 |
| 108 | Papillary thyroid carcinoma (HP:0002895) | 2.02915906 |
| 109 | Depression (HP:0000716) | 2.02336822 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01986363 |
| 111 | Limited hip movement (HP:0008800) | 2.00866624 |
| 112 | Focal seizures (HP:0007359) | 2.00263877 |
| 113 | Heterotopia (HP:0002282) | 1.98349527 |
| 114 | Septo-optic dysplasia (HP:0100842) | 1.98099222 |
| 115 | Exercise-induced muscle cramps (HP:0003710) | 1.97592688 |
| 116 | Wormian bones (HP:0002645) | 1.96566270 |
| 117 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.95909186 |
| 118 | Neurodegeneration (HP:0002180) | 1.95657059 |
| 119 | Postural tremor (HP:0002174) | 1.95144303 |
| 120 | Sensory axonal neuropathy (HP:0003390) | 1.94154091 |
| 121 | Neoplasm of the adrenal cortex (HP:0100641) | 1.89577299 |
| 122 | Athetosis (HP:0002305) | 1.89469051 |
| 123 | Aortic dissection (HP:0002647) | 1.89413949 |
| 124 | Spondylolisthesis (HP:0003302) | 1.89135479 |
| 125 | Thyroid carcinoma (HP:0002890) | 1.89115070 |
| 126 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89010238 |
| 127 | Pelvic girdle muscle weakness (HP:0003749) | 1.88987465 |
| 128 | Flat acetabular roof (HP:0003180) | 1.88967492 |
| 129 | Neonatal hypoglycemia (HP:0001998) | 1.88672875 |
| 130 | Bradykinesia (HP:0002067) | 1.88572854 |
| 131 | Dyskinesia (HP:0100660) | 1.88291748 |
| 132 | Spinal muscular atrophy (HP:0007269) | 1.87840119 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.87024911 |
| 134 | Poor eye contact (HP:0000817) | 1.85903463 |
| 135 | Nausea (HP:0002018) | 1.85702912 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.85578155 |
| 137 | Femoral bowing (HP:0002980) | 1.85569705 |
| 138 | Truncal ataxia (HP:0002078) | 1.85190739 |
| 139 | Hypoplasia of the iris (HP:0007676) | 1.84466308 |
| 140 | Aortic valve stenosis (HP:0001650) | 1.83191662 |
| 141 | Asymmetric growth (HP:0100555) | 1.83101045 |
| 142 | Rigidity (HP:0002063) | 1.82593759 |
| 143 | Abnormality of chromosome segregation (HP:0002916) | 1.81897648 |
| 144 | Abnormality of the motor neurons (HP:0002450) | 1.80523000 |
| 145 | Abnormal neuron morphology (HP:0012757) | 1.80523000 |
| 146 | Myoglobinuria (HP:0002913) | 1.79987392 |
| 147 | Proximal tubulopathy (HP:0000114) | 1.79892525 |
| 148 | Follicular hyperkeratosis (HP:0007502) | 1.79855614 |
| 149 | Biliary tract neoplasm (HP:0100574) | 1.79185024 |
| 150 | Elbow flexion contracture (HP:0002987) | 1.78637254 |
| 151 | Dialeptic seizures (HP:0011146) | 1.78336347 |
| 152 | Achilles tendon contracture (HP:0001771) | 1.78302955 |
| 153 | Embryonal renal neoplasm (HP:0011794) | 1.77506729 |
| 154 | Craniofacial hyperostosis (HP:0004493) | 1.77491415 |
| 155 | Stereotypic behavior (HP:0000733) | 1.77163945 |
| 156 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.77142528 |
| 157 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76834744 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.76112614 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76112614 |
| 160 | Difficulty climbing stairs (HP:0003551) | 1.74535567 |
| 161 | Impaired smooth pursuit (HP:0007772) | 1.74508978 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.74321557 |
| 163 | Cholecystitis (HP:0001082) | 1.74321557 |
| 164 | Generalized aminoaciduria (HP:0002909) | 1.74282431 |
| 165 | Metaphyseal cupping (HP:0003021) | 1.72774680 |
| 166 | Entropion (HP:0000621) | 1.72117772 |
| 167 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.71349693 |
| 168 | Loss of speech (HP:0002371) | 1.70937101 |
| 169 | Impulsivity (HP:0100710) | 1.69993128 |
| 170 | Subacute progressive viral hepatitis (HP:0006572) | 1.69966986 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.69746611 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.69746611 |
| 173 | Chromsome breakage (HP:0040012) | 1.69295307 |
| 174 | Abnormality of the Achilles tendon (HP:0005109) | 1.69246738 |
| 175 | Popliteal pterygium (HP:0009756) | 1.69059573 |
| 176 | Macroorchidism (HP:0000053) | 1.68754106 |
| 177 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68622305 |
| 178 | Supranuclear gaze palsy (HP:0000605) | 1.68365034 |
| 179 | Difficulty running (HP:0009046) | 1.68249005 |
| 180 | Neuronal loss in central nervous system (HP:0002529) | 1.68171888 |
| 181 | Steatorrhea (HP:0002570) | 1.68167012 |
| 182 | Testicular neoplasm (HP:0010788) | 1.67457852 |
| 183 | Oligodactyly (HP:0012165) | 1.66767567 |
| 184 | Abnormality of the vocal cords (HP:0008777) | 1.66761562 |
| 185 | Neoplasm of the small intestine (HP:0100833) | 1.66656884 |
| 186 | Atrioventricular canal defect (HP:0006695) | 1.65399077 |
| 187 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64860436 |
| 188 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.64860436 |
| 189 | Spastic tetraparesis (HP:0001285) | 1.64594468 |
| 190 | Restlessness (HP:0000711) | 1.63933109 |
| 191 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.63831327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 5.11682532 |
| 2 | MAP3K9 | 3.77382081 |
| 3 | SCYL2 | 3.09076994 |
| 4 | NTRK3 | 3.08001522 |
| 5 | MOS | 3.04282874 |
| 6 | CAMKK2 | 2.92626501 |
| 7 | FRK | 2.91209387 |
| 8 | PDK3 | 2.82043878 |
| 9 | PDK4 | 2.82043878 |
| 10 | NEK6 | 2.78929669 |
| 11 | BRAF | 2.78564511 |
| 12 | CDK9 | 2.62053892 |
| 13 | NEK1 | 2.59936147 |
| 14 | PRKD3 | 2.51403022 |
| 15 | KSR2 | 2.50513628 |
| 16 | TRIB3 | 2.32900443 |
| 17 | RIPK4 | 2.28607041 |
| 18 | MET | 2.24735149 |
| 19 | MST4 | 2.24413415 |
| 20 | NEK9 | 2.22145351 |
| 21 | CAMKK1 | 2.15154923 |
| 22 | MAP3K12 | 2.13549764 |
| 23 | MAP3K2 | 1.94575952 |
| 24 | TTK | 1.81012320 |
| 25 | MARK3 | 1.74771389 |
| 26 | ARAF | 1.74628152 |
| 27 | BCKDK | 1.72138388 |
| 28 | MAP2K4 | 1.71763869 |
| 29 | ALK | 1.69247909 |
| 30 | PKN2 | 1.61423916 |
| 31 | DAPK1 | 1.60551813 |
| 32 | MELK | 1.60362798 |
| 33 | MINK1 | 1.57764675 |
| 34 | MYLK | 1.52730767 |
| 35 | MAP3K4 | 1.50488994 |
| 36 | TRPM7 | 1.48984316 |
| 37 | PDK2 | 1.47559291 |
| 38 | BRSK2 | 1.38165070 |
| 39 | RIPK1 | 1.37394099 |
| 40 | TAOK3 | 1.31302582 |
| 41 | NTRK1 | 1.31076611 |
| 42 | TIE1 | 1.30667189 |
| 43 | PINK1 | 1.30509679 |
| 44 | MAP2K1 | 1.29806726 |
| 45 | RET | 1.28890016 |
| 46 | LMTK2 | 1.25201686 |
| 47 | STK24 | 1.23899645 |
| 48 | TGFBR2 | 1.21983753 |
| 49 | PNCK | 1.17864053 |
| 50 | TSSK6 | 1.16941151 |
| 51 | DAPK2 | 1.15854847 |
| 52 | STK38 | 1.15552990 |
| 53 | ZAK | 1.14851934 |
| 54 | LATS2 | 1.12132354 |
| 55 | NEK2 | 1.09260640 |
| 56 | PDK1 | 1.08296526 |
| 57 | AURKA | 1.08238313 |
| 58 | EIF2AK3 | 1.07971536 |
| 59 | EPHA2 | 1.04026256 |
| 60 | PLK2 | 1.03839482 |
| 61 | NUAK1 | 1.03763550 |
| 62 | BMPR2 | 1.03467581 |
| 63 | EPHA4 | 1.02435365 |
| 64 | SGK3 | 1.01624309 |
| 65 | GRK5 | 1.00952526 |
| 66 | PIM1 | 0.98474140 |
| 67 | PBK | 0.97912896 |
| 68 | TGFBR1 | 0.95641043 |
| 69 | TAOK1 | 0.95620777 |
| 70 | STK38L | 0.92088662 |
| 71 | JAK1 | 0.91670960 |
| 72 | MAP3K14 | 0.90988555 |
| 73 | TRIM28 | 0.89975229 |
| 74 | LATS1 | 0.89140753 |
| 75 | CDK12 | 0.88477309 |
| 76 | PIK3CA | 0.87971417 |
| 77 | DMPK | 0.87817465 |
| 78 | FER | 0.87335188 |
| 79 | PDPK1 | 0.86718170 |
| 80 | CDK19 | 0.84667987 |
| 81 | PRKCI | 0.83124020 |
| 82 | STK10 | 0.82958471 |
| 83 | STK3 | 0.82814355 |
| 84 | JAK2 | 0.82057228 |
| 85 | PRKCH | 0.79954756 |
| 86 | MAP3K5 | 0.77324991 |
| 87 | MAP3K1 | 0.77042976 |
| 88 | MATK | 0.73907736 |
| 89 | TEC | 0.73059571 |
| 90 | FLT3 | 0.72601921 |
| 91 | CCNB1 | 0.72565286 |
| 92 | KSR1 | 0.72396534 |
| 93 | ACVR1B | 0.72318513 |
| 94 | FGFR3 | 0.71772376 |
| 95 | TESK1 | 0.70434509 |
| 96 | CDK6 | 0.68902306 |
| 97 | AKT3 | 0.68861986 |
| 98 | RAF1 | 0.67970096 |
| 99 | ERBB3 | 0.67083145 |
| 100 | PRKCG | 0.64633446 |
| 101 | PIK3CG | 0.64554745 |
| 102 | PDGFRA | 0.64434497 |
| 103 | CDK7 | 0.63615935 |
| 104 | BMPR1B | 0.60644467 |
| 105 | PLK1 | 0.60611245 |
| 106 | MAP3K6 | 0.58308869 |
| 107 | STK39 | 0.57899461 |
| 108 | SGK2 | 0.57836099 |
| 109 | CDK5 | 0.57314631 |
| 110 | PTK6 | 0.56634294 |
| 111 | HIPK2 | 0.55352088 |
| 112 | TYRO3 | 0.54433479 |
| 113 | JAK3 | 0.54307913 |
| 114 | BRSK1 | 0.53224847 |
| 115 | PAK2 | 0.52507838 |
| 116 | PRKG1 | 0.52487469 |
| 117 | PRKAA1 | 0.51605222 |
| 118 | ERN1 | 0.51302489 |
| 119 | PAK6 | 0.50422649 |
| 120 | TNIK | 0.46034145 |
| 121 | ILK | 0.45421697 |
| 122 | OBSCN | 0.43799749 |
| 123 | MAP2K7 | 0.43236582 |
| 124 | NME1 | 0.42909910 |
| 125 | RPS6KA4 | 0.41772345 |
| 126 | PDGFRB | 0.41759434 |
| 127 | PTK2 | 0.40729038 |
| 128 | RPS6KB1 | 0.40022668 |
| 129 | ABL2 | 0.39609834 |
| 130 | MAP2K3 | 0.38137057 |
| 131 | TTN | 0.37297666 |
| 132 | MAP3K11 | 0.36679493 |
| 133 | ZAP70 | 0.35941137 |
| 134 | MAPK10 | 0.35722092 |
| 135 | WNK1 | 0.35718250 |
| 136 | CHUK | 0.35095012 |
| 137 | RPS6KA3 | 0.34833133 |
| 138 | MUSK | 0.34054022 |
| 139 | NTRK2 | 0.33928752 |
| 140 | CSNK1G2 | 0.30885943 |
| 141 | PRPF4B | 0.30646776 |
| 142 | EGFR | 0.30579789 |
| 143 | MAP3K8 | 0.30480782 |
| 144 | CSNK1E | 0.30347820 |
| 145 | CSNK1D | 0.29938894 |
| 146 | SIK2 | 0.29762834 |
| 147 | PLK3 | 0.28660818 |
| 148 | PAK1 | 0.28110701 |
| 149 | STK11 | 0.28032050 |
| 150 | MAPK7 | 0.27103151 |
| 151 | RPS6KA2 | 0.26695197 |
| 152 | DDR2 | 0.26606049 |
| 153 | CDK3 | 0.25992659 |
| 154 | PKN1 | 0.25506048 |
| 155 | PLK4 | 0.25311346 |
| 156 | SGK1 | 0.24069595 |
| 157 | PRKG2 | 0.22729435 |
| 158 | CAMK2G | 0.22291979 |
| 159 | MAPK1 | 0.21829131 |
| 160 | TNK2 | 0.21425888 |
| 161 | CSF1R | 0.19120932 |
| 162 | CAMK2A | 0.19107505 |
| 163 | CDK8 | 0.17412925 |
| 164 | PTK2B | 0.16559070 |
| 165 | IRAK3 | 0.15803219 |
| 166 | CDK2 | 0.15480754 |
| 167 | PRKCQ | 0.15294105 |
| 168 | EPHB2 | 0.14909088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.36882622 |
| 2 | Basal transcription factors_Homo sapiens_hsa03022 | 3.09191940 |
| 3 | Cell cycle_Homo sapiens_hsa04110 | 2.79289261 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.71619054 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.66548878 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63445285 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38897893 |
| 8 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.86972455 |
| 9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.86357538 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.81017581 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.77433754 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76710901 |
| 13 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.74458621 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73215142 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66275799 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.64851258 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64807151 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.62878750 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61165176 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57442387 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.51488980 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49710026 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48004377 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47805340 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.46528188 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.43275233 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.41596426 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.39243079 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.33391027 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32939401 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.32373011 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32143880 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30928214 |
| 34 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.30854469 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27622394 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27608173 |
| 37 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.25646173 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.25231540 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.25215616 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23956477 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.23746940 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.22668215 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.21328855 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.20198390 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19541082 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19483811 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17280348 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15939511 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15632759 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14214497 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.13893455 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12961221 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12713782 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.10391302 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.10166958 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 1.09828585 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 1.08956680 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.08936368 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08507668 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08457628 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07286721 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06519463 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05688008 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04088913 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 1.03518542 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03229343 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00974519 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00860143 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99229462 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.97393049 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97093925 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96910994 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96279115 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96187739 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95594473 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95028459 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94988308 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94489632 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92537253 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92416102 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92244764 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.91695142 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90334216 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89783929 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89595933 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87796620 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87391062 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.87106415 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86692710 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86108036 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86065261 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86045141 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.85813661 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85614763 |
| 95 | Melanoma_Homo sapiens_hsa05218 | 0.85554872 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84971389 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.84220723 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83946149 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82743593 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.82298981 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81853925 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81781829 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80764378 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.79445144 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79111385 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78128316 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77330142 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.76668978 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76144119 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.75654740 |
| 111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74432704 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74293592 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73148462 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71824469 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71810200 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71305760 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70784944 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.69408461 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67718859 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67618531 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67560093 |
| 122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67508462 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67291038 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.67168224 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66664434 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65913642 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65651285 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65583930 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.65580390 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.64590936 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64548010 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64280763 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63934150 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63018673 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61570018 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.61448722 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.60513376 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60121276 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.57924976 |
| 140 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57421889 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57284452 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56653277 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54997008 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54716100 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54377308 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54059673 |
| 147 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53580258 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53312965 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52507970 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52109472 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51977613 |
| 152 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51652017 |
| 153 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50974479 |
| 154 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50949952 |
| 155 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49359909 |
| 156 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48043224 |
| 157 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47959066 |
| 158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47682853 |
| 159 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46900926 |
| 160 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45363808 |
| 161 | Salmonella infection_Homo sapiens_hsa05132 | 0.43709146 |
| 162 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43677029 |
| 163 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43153333 |
| 164 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42510370 |
| 165 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42364654 |
| 166 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42170019 |
| 167 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41809726 |

